Pharmacologic Pain Treatment in a Multidisciplinary Pain Center

2010 ◽  
Vol 26 (2) ◽  
pp. 81-86 ◽  
Author(s):  
Susan Broekmans ◽  
Fabienne Dobbels ◽  
Koen Milisen ◽  
Bart Morlion ◽  
Steven Vanderschueren
2017 ◽  
Vol 16 (1) ◽  
pp. 188
Author(s):  
H.L.A. Kristensen ◽  
M. Madsen ◽  
P.B.F. Jensen ◽  
W.Z. Pawlak

AbstractBackgroundTreatment of patients with chronic nonmalignant pain (CNMP) is challenging and requires a multidisciplinary effort. In a multidisciplinary pain center, patients are treated by a team of doctor, nurse, physiotherapist, psychologist and social worker. Especially in the beginning of treatment patients receive much information. Many patients and their relatives have problems with comprehending it.ObjectiveThis is an action research study aimed to find the optimal mode for to introduce patients with CNMP and their relatives to the multidisciplinary pain treatment.MethodIn the fall of 2016, we began to invite patients and their relatives to the introduction meeting (IM), which takes place in groups of up to 20 people, has duration of 1 hour and is led by the physiotherapist and nurse, but the physician is also present. Invited patients are able to understand written and oral Danish and are not suffering from social phobias. During IM facts about the center, treatment course and pain physiology are presenter. Immediately after IM, participants are anonymously asked about their experiences.ResultsUp to date (February 2017) 254 patients were invited. Invitation was rejected by 63 patients (24,8%). Question about understanding of chronic pain was answered by 108 participants (both patients and their relatives), and 103 participants declared better understanding of chronic pain after IM end before. 69 participants answered question about understanding of treatment course in the center. All but 2 participants declared after IM at their understanding was better end before. In fact, 31 (44,9%) participants estimated changes in understanding of treatment course as much significant.ConclusionThe IM at the beginning of multidisciplinary therapy seems to be a promising activity for patients with CNMP referred to the multidisciplinary pain center, as well as for their relatives. Study is ongoing and updated results will be presented at the conference.


Pain Medicine ◽  
2008 ◽  
Vol 9 (7) ◽  
pp. 786-794 ◽  
Author(s):  
Philip Peng ◽  
Paul Tumber ◽  
Michael Stafford ◽  
Doug Gourlay ◽  
Patrick Wong ◽  
...  

2015 ◽  
Vol 27 (9) ◽  
pp. 2901-2905 ◽  
Author(s):  
Kazuhiro Hayashi ◽  
Young-Chang P. Arai ◽  
Tatsunori Ikemoto ◽  
Makoto Nishihara ◽  
Shigeyuki Suzuki ◽  
...  

1989 ◽  
Vol 68 (4) ◽  
pp. 549
Author(s):  
Christine Peeters-Asdourian

2021 ◽  
Author(s):  
Amélie BOURSIER ◽  
Laurie Ferret ◽  
Julie Fulcrand ◽  
Julie Delvoye - Heiremans ◽  
Pascal Charpentier ◽  
...  

Abstract Background:In January 2017, two clinical pharmacists joined our institution’s multidisciplinary pain center care team. They help optimize management of chronic pain patients. The purpose of this study is to present and discuss an innovative model of clinical pharmacy development in France.Method:A retrospective study for the period January 1, 2017 to June 30, 2019 was conducted.The care team evaluated the clinical pharmacy service using a satisfaction questionnaire.The outcome measures were the type of activities, number of interventions and healthcare team satisfaction.Results:During this period, the clinical pharmacists intervened 1839 times. Conventional clinical pharmacy activities do not represent the majority of solicitations, which shows the advantage of both adapting the activities deployed to the expectations of care teams and expanding care packages to those needs.Pharmaceutical advice was the main activity, mostly given to physicians (55%) and patients (35%).They consisted in contributing to the choice of drug strategy, explaining the treatment, adjusting a dosage, and improving relations between hospital and community caregivers.The feedback forms showed that caregivers believe that clinical pharmacy has positive impacts on patient care and healthcare team quality of life. Conclusion:The numerous requests for clinical pharmacist interventions show the care team’s significant interest in this new activity. Clinical pharmacy has shown its added value in patient quality of care and helps optimize the patient's care pathway by decompartmentalizing hospital and community medicine.This clinical pharmacy development model is innovative in France, as pharmacists are full members of the care team. Specific activities were set up progressively according to the care team’s needs. Caregivers’ expectations and requests made in clinical pharmacy progressed over time to more specialized activities. Assessment of team satisfaction showed that this model was very well accepted by caregivers and highlights the relevance of adapting and specializing clinical pharmacy development to the care team’s needs.


1993 ◽  
Vol 9 (1) ◽  
pp. 3-15 ◽  
Author(s):  
David A. Fishbain ◽  
Hubert L. Rosomoff ◽  
Myron Goldberg ◽  
Robert Cutler ◽  
Elsayed Abdel-Moty ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document